AMW GmbH

Controlled drug delivery for superior treatment. For patients, worldwide. AMW’s mission as a specialty pharmaceutical company is to provide patients and our partners with value-added medicines for improved adherence and cost-effective therapies. With our focus on biodegradable controlled-release drug delivery systems suited for almost any indication, we build on our growing development pipeline. Based on our unparalleled expertise in formulation development, we collaborate with pharma and biotech partners worldwide to develop and manufacture high-quality products and life-cycle solutions. We cover the entire value chain, from (co-)development to manufacturing and international commercialization via direct sales and out-licensing. Our experienced and agile team of drug delivery experts dedicated to improving patients’ lives, are crucial to our success. Our unique expertise in formulation development and technology application allows us to design, manufacture and commercialize high-quality biodegradable controlled-release drug delivery systems. AMW has two approved medicinal products, implants releasing goserelin and leuprorelin, which are distributed worldwide via direct sales and out-licensing.